Precision Assessment of Platelet Rich Plasma for Joint Preservation

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-04-02

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Knee Osteoarthritis (OA) is a leading cause of premature disability in Veterans who develop knee OA at higher rates and younger ages than the population in general. For those with symptomatic early knee OA, who are years to decades away from meeting clinical indications for knee replacement surgery, knee injections have been a key treatment option. In recent years, platelet rich plasma (PRP) injections have gained increasing attention for improving pain and function in patients with knee OA. Basic science studies also suggest that PRP may also potentially stimulate repair responses to articular cartilage. However, the mechanisms of action of PRP in the treatment of knee OA are unknown. Because autologous blood is used, the PRP composition differs between patients. It is also unknown whether these differences in PRP composition affect clinical outcomes. This study will address these gaps and provide critical new and objective information on PRP treatment effects in Veterans and additional women with early knee OA important to improving clinical use of this new treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Validation of a Low-cost Platelet-Rich Plasma (PRP)

NCT06184048

Platelet-Rich Plasma (PRP) Knee Osteoarthritis (OA)

COMPLETED NA

Platelet Rich Plasma Injection for Knee Pain

NCT01747018

Degenerative Chondropathy Early Osteoarthritis

COMPLETED PHASE1/PHASE2

Pilot Synovial Fluid Molecular/Stem Cell Response to PRP in Knee Osteoarthritis: Clinical & Imaging Outcome Correlation

NCT02468492

Knee Osteoarthritis

COMPLETED EARLY_PHASE1

Comparative Evaluation of A-CP HA Kit, Hyaluronic Acid and Placebo for the Treatment of Knee Osteoarthritis

NCT03201614

Knee Osteoarthritis

UNKNOWN NA

Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis

NCT04006314

Knee Osteoarthritis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Because very little is known about either the mechanisms of action or objective clinical outcomes of PRP treatment for knee OA, the investigators propose a prospective "pre-post" study that will permit us to identify areas where more rigorous clinical outcomes and mechanistic research may be warranted. The proposed work includes special elements of: (1) quantitative metrics to assess clinical outcomes, (2) correlation of candidate beneficial proteins with clinical outcomes, and (3) proteomic evaluation of the injected PRP. This work will use an innovative multi-disciplinary, personalized approach to evaluate the effects of PRP composition on both function, as assessed by patient-reported outcomes and gait analysis, and cartilage matrix structure as assessed by quantitative MRI

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PRP

Symptomatic early knee osteoarthritis subjects who have elected to receive PRP treatment.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* symptomatic early knee OA
* full weight-bearing status
* have elected to receive PRP treatment
* Male veterans
* Female veterans

Exclusion Criteria

* inflammatory arthritis, gout or recurrent pseudogout
* symptomatic OA of other lower extremity joints
* BMI \>35 kg/m2
* use of walking, orthopedic, or prosthetic assistive device
* severe systemic disease defined as American Society of Anesthesiologists (ASA) 3 or above56
* inability to have MRI
* pregnant or intending to become pregnant during the study
* predominantly patellofemoral disease

Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No